Cited by 802Cell Adhesion Molecules ResearchNF-κB Signaling PathwaysChemokine receptors and signaling

Intercellular adhesion molecule-1

van de Stolpe, A., van der Saag, P. T.·1996·Journal of Molecular Medicine

Abstract

The intercellular adhesion molecule (ICAM) 1 is an Ig-like cell adhesion molecule expressed by several cell types, including leukocytes and endothelial cells. It can be induced in a cell-specific manner by several cytokines, for example, tumor necrosis factor-alpha, interleukin-1, and interferon-gamma, and inhibited by glucocorticoids. Its ligands are the membrane-bound integrin receptors LFA-1 and Mac-1 on leukocytes, CD43, the soluble molecule fibrinogen, the matrix factor hyaluronan, rhinoviruses, and Plasmodium falciparum malaria-infected erythrocytes. ICAM-1 expression is predominantly transcriptionally regulated. The ICAM-1 promoter contains several enhancer elements, among them a novel kappa B element which mediates effects of 12-O-tetradecanoylphorbol-13-acetate, interleukin-1, lipopolysaccharide, tumor necrosis factor-alpha, and glucocorticoids. Expression regulation is cell specific and depends on the availability of cytokine/hormone receptors, signal transduction pathways, transcription factors, and posttranscriptional modification. ICAM-1 plays a role in inflammatory processes and in the T-cell mediated host defense system. It functions as a costimulatory molecule on antigen-presenting cells to activate MHC class II restricted T-cells, and on other cell types in association with MHC class I to activate cytotoxic T-cells. ICAM-1 on endothelium plays an important role in migration of (activated) leukocytes to sites of inflammation. ICAM-1 is shed by the cell and detected in plasma as sICAM-1. Regulation and significance of sICAM-1 are as yet unclear, but sICAM-1 is increased in many pathological conditions. ICAM-1 may play a pathogenetic role in rhinovirus infections. Derangement of ICAM-1 expression probably contributes to the clinical manifestations of a variety of diseases, predominantly by interfering with normal immune function. Among these are malignancies (e.g., melanoma and lymphomas), many inflammatory disorders (e.g., asthma and autoimmune disorders), atherosclerosis, ischemia, certain neurological disorders, and allogeneic organ transplantation. Interference with ICAM-1 leukocyte interaction using mAbs, soluble ICAM-1, antisense ICAM-1 RNA, and in the case of melanoma mAb-coupled immunotoxin, may offer therapeutic possibilities in the future. Integration of knowledge concerning membrane-bound and soluble ICAM-1 into a single functional system is likely to contribute to elucidating the immunoregulatory function of ICAM-1 and its pathophysiological significance in various disease entities.

Integrity signals

Registry

Crossref · 10.1007/bf00202069

Cites

319 of 319 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IGSF21, along with other members of the IGSF superfamily, has functions linked to endometriosis.

    “The IGSF21, along with other members of the IGSF superfamily, has functions linked to endometriosis.”

    From Altered genome-wide methylation in endometriosis (2014) · cites this paper as [50]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
van de Stolpe, A., & van der Saag, P. T.
Venue
Journal of Molecular Medicine
Published
1996-01
Volume
74
Issue
1
Pages
13-33
ISSN
  • 0946-2716 (ISSN-L)
  • 1432-1440
OpenAlex
W1530203607
Cited by
802
References
319
Citations by year
2026: 6 · 2025: 12 · 2024: 17 · 2023: 23 · 2022: 23 · 2021: 22 · 2020: 6 · 2019: 13 · 2018: 10 · 2017: 14 · 2016: 21 · 2015: 23 · 2014: 28 · 2013: 32 · 2012: 34
FWCI
11.71
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Molecular Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
Keywords
ICAM-1, soluble ICAM-1, adhesion molecules, integrins, LFA-1, Mac-1, cytokine induction, transcriptional regulation, leukocyte migration, T cell costimulation, inflammation, rhinovirus infection, melanoma, lymphoma, autoimmune disease, atherosclerosis, organ transplantation
MeSH terms
Animals, Base Sequence, Cell Adhesion, DNA, Forecasting, Gene Expression Regulation, Humans, Leukocytes, Ligands, Molecular Sequence Data, Molecular Structure, Intercellular Adhesion Molecule-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review